Benzinga | Dec 1, 2020 06:30AM EST

HC Wainwright & Co. Maintains Neutral on Sage Therapeutics, Lowers Price Target to $74

HC Wainwright & Co. maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price target from $81 to $74.